Research and Markets has announced the addition of the "Ventricular Arrhythmia - Pipeline Insights, 2017" report to their offering.
Ventricular Arrhythmia - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Ventricular Arrhythmia.
The This report covers the product profiles in various stages of development including Discovery, Pre - clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Ventricular Arrhythmia.
This report also assesses the Ventricular Arrhythmia therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
Key Topics Covered:
- Ventricular Arrhythmia Overview
- Ventricular Arrhythmia Disease Associated
- Ventricular Arrhythmia Pipeline Therapeutics
- Ventricular Arrhythmia Therapeutics under Development by Companies
- Ventricular Arrhythmia Filed and Phase III Products
- Ventricular Arrhythmia Phase II Products
- Ventricular Arrhythmia Phase I and IND Filed Products
- Ventricular Arrhythmia Discovery and Pre-Clinical Stage Products
- Drug Candidate Profiles
- Ventricular Arrhythmia - Therapeutics Assessment
- Ventricular Arrhythmia - Discontinued Products
- Ventricular Arrhythmia - Dormant Products
- Companies Involved in Therapeutics Development for Ventricular Arrhythmia
- Appendix
For more information about this report visit http://www.researchandmarkets.com/research/286l67/ventricular
View source version on businesswire.com: http://www.businesswire.com/news/home/20170123005712/en/